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Nico Melzer1*†, Gordon Hicking1†, Stefan Bittner1, Nicole Bobak1, Kerstin Göbel1, Alexander M Herrmann1,
Heinz Wiendl1† and Sven G Meuth1,2Abstract
Background: Neural-antigen reactive cytotoxic CD8+ T cells contribute to neuronal dysfunction and degeneration
in a variety of inflammatory CNS disorders. Facing excess numbers of target cells, CNS-invading CD8+ T cells cause
neuronal cell death either via confined release of cytotoxic effector molecules towards neurons, or via spillover of
cytotoxic effector molecules from ‘leaky’ immunological synapses and non-confined release by CD8+ T cells
themselves during serial and simultaneous killing of oligodendrocytes or astrocytes.
Methods: Wild-type and T cell receptor transgenic CD8+ T cells were stimulated in vitro, their activation status was
assessed by flow cytometry, and supernatant glutamate levels were determined using an enzymatic assay. Expression
regulation of molecules involved in vesicular glutamate release was examined by quantitative real-time PCR, and
mechanisms of non-vesicular glutamate release were studied by pharmacological blocking experiments. The impact
of CD8+ T cell-mediated glutamate liberation on neuronal viability was studied in acute brain slice preparations.
Results: Following T cell receptor stimulation, CD8+ T cells acquire the molecular repertoire for vesicular glutamate
release: (i) they upregulate expression of glutaminase required to generate glutamate via deamination of glutamine
and (ii) they upregulate expression of vesicular proton-ATPase and vesicular glutamate transporters required for filling
of vesicles with glutamate. Subsequently, CD8+ T cells release glutamate in a strictly stimulus-dependent manner. Upon
repetitive T cell receptor stimulation, CD25high CD8+ T effector cells exhibit higher estimated single cell glutamate
release rates than CD25low CD8+ T memory cells. Moreover, glutamate liberation by oligodendrocyte-reactive CD25high
CD8+ T effector cells is capable of eliciting collateral excitotoxic cell death of neurons (despite glutamate re-uptake by
glia cells and neurons) in intact CNS gray matter.
Conclusion: Glutamate release may represent a crucial effector pathway of neural-antigen reactive CD8+ T cells,
contributing to excitotoxicity in CNS inflammation.
Keywords: Glutamate excitotoxicity, Neuronal cell death, CNS tissue damage, CD8+ T cellsIntroduction
Cytotoxic CD8+ T cells directed against neuronal or glial
antigens contribute to neuronal cell death in a variety
of inflammatory CNS disorders [1-3]. They are capable
of harming neuronal function and integrity either by
directly targeting neurons and their neurites or by exerting* Correspondence: nico.melzer@ukmuenster.de
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reproduction in any medium, provided the ortheir action via ‘collateral’ mechanisms of neuronal
damage that might follow destruction of oligodendrocytes
(ODCs), myelin sheaths or astrocytes in the CNS gray
and white matter [4].
Recently, we have shown that activated T cell receptor
(TCR)-transgenic, ovalbumin (OVA)-reactive CD8+ T
cells (OT-I cells [5]) are capable of initiating ‘collateral’
neuronal apoptosis in the gray matter of otherwise
non-inflamed acute brain slices from ODC-OVA mice
selectively expressing OVA in ODCs under the control
of a truncated myelin basic protein (MBP)-promotorLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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part due to release of perforin (and granzymes) whereas
Fas-ligand (FasL) - Fas-receptor (Fas) interactions were
not relevant [7-9]. However, a certain part of the collateral
neuronal cell death induced by CD8+ T cells remained
unexplained [7,10].
During culture of polyclonally activated CD3+ T cells,
high levels of extracellular glutamate have been shown
to accumulate, which are efficiently cleared if T cells are
co-cultured with astrocytes [11]. In turn, the T cell-derived
glutamate elicits the release of thiols (cysteine, glutathione
and cysteinyl-glycine) and lactate from astrocytes, which
reduce neuronal apoptosis induced by oxidative stress
[11]. However, whether glutamate derived from T cells
migrating through the intact CNS parenchyma and
scanning for their cognate antigen may also exert
excitotoxic neuronal cell death, is unclear at present.
Methods
Mice
Wild-type (WT), ODC-OVA [6] and OT-I [5] mice were
kept at the animal facility of the University of Münster,
Germany, and had access to food and water ad libitum.
All experiments were conducted according to the German
law of animal protection and were approved by local
authorities. All transgenic mice were created on or back-
crossed to a C57BL/6 genetic background for at least
ten generations.
Isolation of splenocytes and stimulation of CD8+ T cells
Spleens of WT or OT-I mice were removed and single
cell suspensions were generated by mashing spleens
through a 70 μm strainer and lysing red blood cells with
ammonium-chloride-potassium (ACK) buffer. Splenocytes
were cultured in glutamine-containing DMEM-based
standard medium consisting of DMEM (BioWhittaker,
Verviers, Belgium) supplemented with 5% FCS (PAA
Laboratories, Pasching, Germany), 10 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES, Gibco,
Invitrogen, Darmstadt, Germany), 2 mM L-glutamine
(PAA Laboratories, Pasching, Germany), 50 μM 2-mer-
captoethanol (Gibco, Invitrogen, Darmstadt, Germany),
1% non-essential amino acids (BioWhittaker, Verviers,
Belgium) and 25 μg/ml gentamicin (Gibco, Invitrogen,
Darmstadt, Germany).
For in vitro T cell stimulation experiments, CD8+ T cells
were isolated from WT splenocytes using the respective
MACS® T cell isolation kit (Miltenyi, Bergisch Gladbach,
Germany) according to the manufacturer’s instructions.
This yielded a purity of about 90% of CD3+ CD8+ T
cells (Additional file 1: Figure S1A, B). CD8+ T cells
from WT mice were cultured for different periods of
time at a density of 1 × 106/well on 24-well plates with
anti-CD3/CD28 beads (Dynal Biotech, Oslo, Norway) atdifferent bead-to-cell ratios in the absence or presence
of certain glutamate release blockers (all from Sigma-
Aldrich, München, Germany) or were left unstimulated.
In a subset of experiments, CD8+ T cells from WT mice
were stimulated in glutamine-free DMEM-based medium
(BioWhittaker, Verviers, Belgium). After three days of
stimulation, supernatants were removed and analyzed for
IFNγ using a mouse-IFNγ-ELISA kit according to the
manufacturer’s protocol (Duoset, R&D Systems, Wies-
baden, Germany).
For in vitro T cell stimulation experiments, splenocytes
from OT-I mice were plated at a density of 1 × 107/well
on 12-well plates and primed by incubation for five days
with OVA-peptide257-264 (SIINFEKL; 1 nM) and IL-2
(500 U/ml). On day three, supernatants were removed,
analyzed for IFNγ using a mouse-IFNγ-ELISA kit
according to the manufacturer’s protocol (Duoset, R&D
Systems, Wiesbaden, Germany) and substituted by fresh
medium. On day four, again 500 U/ml of IL-2 were added
to the medium. In a subset of experiments, OT-I T cells
were repetitively stimulated by incubation with OVA-
peptide257-264 (SIINFEKL; 1 nM) and IL-2 (500 U/ml)
every three days for a total of fifteen days.
Flow cytometry
Before and after various time periods of in vitro culture,
flow cytometry of stimulated WT CD8+ T cells and OT-I
cells was performed using standard methods. For analysis
of T cell subtype distribution, cells were stained for 20
minutes with allophycocyanin (APC)-labeled anti-mouse
CD3, phycoerythrin (PE)-labeled anti-mouse CD8 and
fluorescein isothiocyanate (FITC)-labeled anti-mouse CD4
(all BD Bioscience, Heidelberg, Germany). As isotype
controls, cells were stained with APC-labeled anti-mouse
IgG1, PE-labeled anti-mouse IgG1 or FITC-labeled anti-
mouse IgG1 (all by BD Bioscience, Heidelberg, Germany).
For analysis of T cell activation markers, cells were
stained for 20 minutes with FITC-labeled anti-mouse CD25
or FITC-labeled anti-mouse CD69 (all BD Bioscience,
Heidelberg, Germany). For analysis of T cell viability, cells
were stained for 20 minutes with FITC-labeled anti-mouse
Annexin V (BD Bioscience, Heidelberg, Germany) and
propidium iodide (PI). All antibodies were titrated for
optimal staining. Flow cytometry analysis was performed
using a FACSCalibur® system (BD Biosciences, Heidelberg,
Germany) and results were analyzed using CellQuest
Pro Software (BD Bioscience, Heidelberg, Germany).
Determination of supernatant glutamate levels
Supernatant glutamate levels were determined at dif-
ferent time points of in vitro stimulation of WT
CD8+ T cells and OT-I cells using a commercially
available enzymatic determination kit (Glutamine-
Glutamate Kit, Sigma-Aldrich, München, Germany)
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tamate levels were determined in the absence of cells
and subtracted from those obtained during incubation
and stimulation of cells. All pharmacological blockers
used did not interfere with measurements of fixed con-
centrations of glutamate.
For estimation of single cell glutamate secretion rates,
splenocytes from OT-I mice were plated at a density of
1 × 107/well on 12-well plates and iteratively stimulated
by incubation for time intervals of 72 hours with OVA-
peptide257-264 (SIINFEKL; 1 nM) and IL-2 (500 IU/ml)
for a total of 15 days. Numbers (N) of CD8+ T cells were
determined by resuspending and counting total cell
numbers/well at the beginning (b) and the end (e) of
each interval and multiplying each by the percentage
of CD3+ CD8+ T cells as determined by standard flow
cytometry. Cumulative glutamate concentrations ([Glu])
were determined at the end (e) of each time interval as
described. Volumes (V) of the culture medium were
determined at the beginning (b) and the end (e) of the
individual time intervals. Single cell glutamate secretion
rates (ΔGlu/Δt/CD8 T cell) during repetitive stimulation
were calculated using the following formula:
ΔGlu
Δt
CD8Tcell
¼ Glu½ e
VbþVe
2
 
NCD8Tcellsð Þbþ NCD8Tcellsð Þe
2
Quantitative real-time PCR
For analysis of glutaminase-, vesicular (V-type) proton
ATPase-, and vesicular glutamate transporter (VGluT)
1-3-mRNA expression regulation, RNA was purified
using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and
complementary DNA (cDNA) synthesis was performed
using a standard protocol with random hexamer primers
(all reagents were purchased from Applied Biosystems,
Foster City, CA, USA) from WT CD8+ T cells before and
after three days of anti-CD3/CD28 bead-stimulation.
cDNA was used in quantitative real-time PCR (qRT-PCR)
assays with specific TaqMan® primers and probes for
murine glutaminase (Mm01257297_m1), V-type proton
ATPase (Mm01222963_m1), VGluT1 (Mm00812886_m1),
VGluT2 (Mm00499876_m1) and VGluT3 (Mm008054
13_m1, all Applied Biosystems, Foster City, CA, USA)
as well as primers for 18sRNA (Hs_4319413E; Applied
Biosystems, Foster City, CA, USA) as endogenous control.
qRT-PCR was performed according to the manufacturer’s
protocol.
Neuronal cell culture and glutamate excitotoxicity assays
Neuronal cell cultures were obtained from WT C57BL/6
mice embryos (E18) following previously described
protocols [12]. Pregnant mice were killed by cervical
dislocation and embryos were removed and transferredinto warmed Hank’s balanced salt solution (HBSS, Gibco,
Darmstadt, Germany). After preparation of hippocampi,
tissue was collected in 5 ml of 0.25% trypsin in HBSS.
After five minutes of incubation at 37°C, tissue was
washed twice with HBSS and dissociated in 1 ml of
neuronal medium (10% 10× modified Earl’s medium
(MEM), 0.2205% sodium bicarbonate, 1 mM sodium
pyruvate, 2 mM L-glutamine, 2% B27 supplement (all
Gibco, Darmstadt, Germany), 3.8 mM glucose (Merck,
Darmstadt, Germany), 1% penicillin/streptomycin (Biochrom
AG, Berlin, Germany)) by triturating with fire polished
Pasteur pipettes of decreasing tip diameter. Neurons
were diluted in neuronal medium and plated at a density
of 60,000 cells/cm2 on poly-D-lysine (Sigma-Aldrich,
München, Germany) coated cover-slips placed in four-
well plates (Nunc, Roskilde, Denmark). All neuronal cell
cultures were maintained at 37°C and 5% CO2 for up to
five to seven days prior to experiments. The neuronal
cell culture system exhibited a purity of about 80% [12].
After experiments, neurons were fixed with 4% para-
formaldehyde (PFA, Merck, Darmstadt, Germany), washed
three times with 10 mM PBS, and incubated for seven
hours at 4°C in 10 mM PBS containing 5% BSA, (Sigma-
Aldrich, München, Germany), 0.2% Triton X-100 (Sigma-
Aldrich, München, Germany) and 1% normal goat serum.
Slices were then incubated with antibodies to NeuN
(1:1,000, Chemicon, Billerica, MA, USA) or MAP2 a/b
(1:200, Abcam, Cambridge, UK) and activated caspase-3
(1:400, Cell Signaling, Boston, MA, USA) overnight at 4°C.
Secondary antibodies were Alexa Fluor 488-coupled goat
anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) and
Cy3-coupled goat anti-rabbit IgG (Dianova, Hamburg,
Germany) (one hour, RT). Negative controls were obtained
by either omitting the primary or secondary antibody
and gave no signal (data not shown). Finally, cultures
were washed three times and subsequently covered with
ProLong Gold Antifade Reagent with DAPI (Invitrogen,
Carlsbad, CA, USA). Pictures were collected by immu-
nofluorescence microscopy (Axiophot; Zeiss, Oberkochen,
Germany).
Analysis of excitotoxic neuronal cell damage was per-
formed via two distinct experimental approaches: (i)
cultured neurons were incubated for 30 minutes with
standard artificial cerebrospinal fluid (ACSF, for com-
position see below) supplemented with different con-
centrations of L-glutamate (Sigma-Aldrich, München,
Germany) followed by a washout for 30 minutes with
standard ACSF. The proportion of neurons showing focal
swellings (beading [13]) was calculated as a percentage
of all MAP2+ cells; (ii) cultured neurons were incubated
for six hours with standard ACSF (for composition
see below) supplemented with or without L-glutamate
(Sigma-Aldrich, München, Germany) at a concentra-
tion of 100 μM. The proportion of neurons staining
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centage of all NeuN+ cells.
Cytotoxicity assay
50,000 EL-4 cells/well [14] were cultured on white 96-
well microassay plates (Greiner Bio-One, Frickenhausen,
Germany) and incubated with or without OVA-peptide257-264
(SIINFEKL; 1 nM) for six hours. Alternatively, 50,000 EG-7
cells/well [15] constitutively expressing OVA were cultured
on white 96-well microassay plates (Greiner Bio-One,
Frickenhausen, Germany). Afterwards, EL-4 or EG-7 cells
were co-cultured with 50,000 activated OT-I T cells/well
(1:1) in the absence and presence of the N-methyl-D-
aspartate (NMDA-) receptor antagonist (+)-5-methyl-
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
maleate (MK-801; 10 μM, Sigma-Aldrich, München,
Germany) and the L-alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionate (AMPA-)/kainate-receptor antagonist
2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline
(NBQX; 30 μM, Sigma-Aldrich, München, Germany)
for six hours. The amount of ATP in the supernatant
following cell lysis was assessed as a parameter of cell
viability and number using the ATPLite™ Luminescence
Assay System (PerkinElmer, Rodgau-Jügesheim, Germany)
according to the manufacturer’s instructions. Lumines-
cence was measured on a Topcount NXT (PerkinElmer,
Rodgau-Jügesheim, Germany). Experiments were per-
formed in triplicates. As a control, supernatant ATP
levels were determined from 0, 50,000 and 100,000 EL-
4 cells or activated OT-I T cells/well cultured separately
for six hours. Under all conditions, supernatant ATP
levels showed a linear dependence on the number of
cultured cells.
Preparation of acute brain slices and co-culture
experiments with CD8+ T cells
Six- to eight-week old ODC-OVA mice [6] were anes-
thetized with isoflurane and decapitated, the brain was
removed and placed in ice-cold saline containing:
sucrose, 200 mM; piperazine-N,N’-bis(2-ethanesulfonic
acid) (PIPES), 20 mM; KCl, 2.5 mM; NaH2PO4, 1.25
mM; MgSO4, 10 mM; CaCl2, 0.5 mM; dextrose, 10
mM; pH 7.35, adjusted with NaOH. Slices were pre-
pared as 300 μm coronal sections on a vibratome [7].
For incubation with CD8+ T cells, slices were trans-
ferred each into a well of a 12-well plate containing
standard ACSF containing (mM): NaCl, 125 mM; KCl,
2.5 mM; NaH2PO4, 1.25 mM; NaHCO3, 24 mM;
MgSO4, 2 mM; CaCl2, 2 mM; dextrose, 10 mM; pH
adjusted to 7.35 by bubbling with a mixture of 95% O2
and 5% CO2. Each slice was incubated with 5 × 10
5
activated OT-I T cells for six hours in the absence and
presence of MK801 (10 μM) and NBQX (30 μM).
Afterwards slices were harvested and embedded usingOCT compound tissue-tek (Sakura Finetek Europe,
Zoeterwoude, Netherlands) and frozen in liquid nit-
rogen. Ten micrometer coronal cryo-sections were
obtained using a cryostat (Leica CM 1950, Wetzlar,
Germany).Immunofluorescence-staining and -microscopy
Immunohistochemical staining was performed on
10 μm coronary sections. For double labeling, slices
were postfixated in 4% PFA for ten minutes and after-
wards incubated in blocking solution (PBS containing
5% BSA, 1% normal goat serum and 0.2% Triton
X-100). Slices were then incubated simultaneously with
antibodies to NeuN (1:1,000, Chemicon, Billerica, MA,
USA) and activated caspase-3 (1:400, Cell Signaling,
Boston, MA, USA) overnight at 4°C. Secondary anti-
bodies were Alexa Fluor 488-coupled goat anti-mouse
IgG and Cy3-coupled goat anti-rabbit IgG. Negative
controls were obtained by either omitting the primary
or secondary antibody and gave no signal (data not
shown). For quantification of cell densities, sections
were examined with an Axiophot2 microscope (Zeiss,
Oberkochen, Germany) with a CCD camera (Visitron
Systems, Tuchheim, Germany). Cell densities were
determined in preselected fields within the neocortex.Reagent preparations
L-aminoadipic acid (L-AAA), 4-(2-butyl-6,7-dichloro-2-
cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), L-
β-threo-benzyl-aspartate (TBOA), carbenoxolone (carben.),
pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid)
(PPADS), (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cy-
clohepten-5,10-imine maleate (MK801) and 2,3-dihydroxy-
6-nitro-7-sulphamoyl-benzo(F)quinoxaline (NBQX; all
Sigma-Aldrich, München, Germany) were dissolved in
H2O or DMSO as applicable and frozen as aliquots for
further use. The solvent solution in the final experi-
mental solution did not exceed 0.1%.Statistical analysis
All results are presented as mean ± standard error of
the mean (SEM). Statistical analysis was performed
using student’s t-test for normally distributed samples
or Mann–Whitney test for not-normally distributed
datasets [16]. A Bonferroni-corrected ANOVA was
used in case of multiple comparisons. Analysis was
performed using the Sigma Plot 11.0® software (Systat
Software Inc., Erkrath, Germany). P-values < 0.05 were
considered statistically significant (indicated as *) and
P-values < 0.01 were considered highly statistically
significant (indicated as **).
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CD8+ T cells release glutamate by a TCR-stimulus-dependent
mechanism
In a first set of experiments, we isolated naive CD8+ T
cells from splenocytes of WT C57BL/6 mice, stimulated
them polyclonally with and without anti-CD3/CD28-coated
beads at a bead-to-cell ratio of 1:1 in medium containing
2 mM glutamine and determined supernatant glutam-
ate concentrations at distinct time points. Supernatant
glutamate concentrations increased exponentially with
time and reached levels of about 0.5 mM after 72 hours of
bead-stimulation (n = 3 mice, experiments performed
in triplicates; Figure 1A). In contrast, in the absence of
bead-stimulation, supernatant glutamate concentrations
after 72 hours were significantly lower than in its presence
(relative supernatant glutamate: bead-stimulation for 72
hours: 1.0 ± 0.01, no bead-stimulation for 72 hours: 0.17 ±
0.04, P = 0.002, n = 3 mice, experiments performed in
triplicates; Figure 1C). Moreover, supernatant glutamate
concentrations determined after 72 hours of stimulationFigure 1 Activated CD8+ T cells release glutamate putatively by a ves
exponentially with time (A; bead-to-cell ratio of 1:1, medium containing 2 m
depend on the bead-to-cell ratio as a measure of stimulation intensity (B; s
mice, experiments performed in triplicates) during polyclonal stimulation o
liberation by WT CD8+ T cells depends on extracellular glutamine (Gln) and
system Xc-glutamate-cystine exchanger blocked by L-AAA (2.5 mM), volum
acid transporters blocked by TBOA (500 μM), connexin hemi-channels bloc
(100 μM); stimulation for 72 hours at a bead-to-cell ratio of 1:1, medium co
performed in triplicates). (D) Consistent with a vesicular mechanism of glut
levels of glutaminase, vesicular proton ATPase (H+ ATPase), and vesicular g
(n = 3 mice, experiments performed in triplicates).clearly depended on the bead-to-cell ratio as a measure of
stimulation intensity (Figure 1B).
As glutamate has important roles in the intermediary
metabolism, it is present at millimolar concentrations in
the cytosol of most cell types [17]. Cytosolic glutamate
may stem from transamination of α-ketoglutarate by
glutamate dehydrogenase or from deamination of glutam-
ine by glutaminase [17]. Consistent with predominant
synthesis of intracellular glutamate from deamination of
glutamine, supernatant glutamate levels were significantly
reduced following stimulation of CD8+ T cells for 72 hours
in glutamine-free medium (relative supernatant glutamate:
bead-stimulation for 72 hours in glutamine-containing
medium at a bead-to-cell ratio of 1:1: 1.0 ± 0.01, bead-
stimulation for 72 hours in glutamine-free medium at a
bead-to-cell ratio of 1:1: 0.20 ± 0.05, P = 0.003, n = 3 mice,
experiments performed in triplicates; Figure 1C).
To address the mechanism of glutamate release, we
stimulated CD8+ T cells with anti-CD3/CD28-coated beads
at a bead-to-cell ratio of 1:1 in the presence andicular mechanism. (A, B) Supernatant glutamate concentrations rise
M glutamine; n = 3 mice, experiments performed in triplicates) and
timulation for 72 hours, medium containing 2 mM glutamine; n = 3
f WT CD8+ T cells with anti-CD3/28 beads in vitro. (C) Glutamate
is not mediated by a known non-vesicular release mechanism (that is,
e-sensitive anion channels blocked by DCPIB (5 μM), excitatory amino
ked by carbenoxolone (10 μM), or P2× receptors blocked by PPADS
ntaining either 2 or 0 mM glutamine; n = 3 mice, experiments
amate liberation, activated WT CD8+ T cells upregulate expression
lutamate transporters (VGluT 1 to 3) as revealed by quantitative RT-PCR
Melzer et al. Journal of Neuroinflammation 2013, 10:121 Page 6 of 13
http://www.jneuroinflammation.com/content/10/1/121absence of a variety of blockers of non-vesicular glutamate
liberation (Figure 1C): L-aminoadipic acid (L-AAA, 2.5
mM) blocking the system Xc-glutamate-cystine exchanger
(Takeuchi et al., 2006), 4-(2-butyl-6,7-dichloro-2-cyclo-
pentylindan-1-on-5-yl)oxybutyric acid (DCPIB, 5 μM)
blocking volume-sensitive anion channels [18], L-β-threo-
benzyl-aspartate (TBOA, 500 μM) blocking excitatory
amino acid transporters (EAATs; [19]), carbenoxolone
(carben, 10 μM) blocking connexin hemi-channels [13]
and pyridoxal phosphate-6-azo(benzene-2,4-disulfonic
acid) (PPADS, 100 μM) blocking P2× receptors [20].
After 72 hours of stimulation in the presence of each
blocker, cell viability was controlled via flow cytometry
for annexin V and propidium iodide (PI) uptake. As a
consequence of cytotoxic effects, the concentration of
carbenoxolone was reduced from 100 μM [13] to 10 μM
and that of DCPIB was reduced from 20 μM [18] to 5 μM.
Under these experimental conditions the fraction of viable
annexin V- PI- cells was always > 90% (Additional file 1:
Figure S1D). The presence of blockers did not affect the
activation status of CD8+ T cells after 72 hours of stimula-
tion as under all conditions the fraction of activated CD8+
CD25+ T cells was > 95% (Additional file 1: Figure S1C).
None of the tested blockers of non-vesicular glutamate
release mechanisms significantly reduced supernatant
glutamate levels after 72 hours of CD8+ T cell bead-
stimulation (relative supernatant glutamate: bead-stimula-
tion for 72 hours: no blocker: 1.0 ± 0.01; TBOA: 0.92 ±
0.05, P = 0.129; PPADS: 1.03 ± 0.05, P = 0.325; DCPIB:
0.91 ± 0.04, P = 0.296; carbenoxolone: 0.96 ± 0.02, P =
0.312; n = 3 mice respectively, experiments performed
in triplicates; Figure 1C). Moreover, L-AAA caused a
significant increase of supernatant glutamate levels (rela-
tive supernatant glutamate: bead-stimulation for 72 hours:
no blocker: 1.0 ± 0.01; L-AAA: 1.42 ± 0.06, P = 0.01; n = 3
mice respectively, experiments performed in triplicates;
Figure 1C), consistent with a predominant role of the
system Xc-glutamate-cystine exchanger over EAATs
for (re-)uptake of extracellular glutamate during bead-
stimulation of CD8+ T cells.
As we were unable to unambiguously identify a
non-vesicular mechanism of glutamate release from
stimulated CD8+ T cells, we studied the expression
regulation of genes essential for vesicular glutamate re-
lease during anti-CD3/CD28-bead stimulation of WT
CD8+ T cells (Figure 1D). Quantitative real-time qRT-
PCR analysis revealed an up-regulation of expression
levels of glutaminase (3.3 ± 0.9 fold) responsible for the
cytosolic conversion of glutamate from glutamine [17].
Moreover, vesicular proton ATPase (3.6 ± 0.1 fold), re-
quired for vesicle acidification and vesicular glutamate
transporters (VGluT 1: 77.0 ± 12.0 fold; VGluT2: 12.6 ±
7.2 fold; VGluT3: 5.2 ± 1.2 fold; n = 3 mice, all experi-
ments performed in triplicates) required for uptake ofcytosolic glutamate into vesicles [21] showed significant
expression regulation (Figure 1D). These findings point
towards vesicular release as the predominant mechanism
of glutamate liberation by polyclonally activated CD 8+ T
cells.
Antigen-dependent glutamate release from CD8+ T cells
varies with repetitive stimulation
To assess whether CD8+ T cells also secrete glutamate
upon antigen-dependent stimulation, we incubated spleno-
cytes from OT-I mice [5] bearing a transgenic OVA-
reactive TCR with OVA-peptide257-264 (SIINFEKL; 1 nM)
and IL-2 (500 IU/ml). Supernatant glutamate concentra-
tions after 72 hours of incubation with the antigen-peptide
were significantly higher than in its absence (supernatant
glutamate: antigen-peptide stimulation for 72 hours: 1.70 ±
0.07 mM; no antigen-peptide stimulation for 72 hours:
0.09 ± 0.05 mM, P = 0.002, n = 3 mice, experiments
performed in triplicates; Figure 2A). The same was true
for supernatant IFNγ levels (supernatant IFNγ: antigen-
peptide stimulation for 72 hours: 3,325 ± 34 pg/ml; no
antigen-peptide stimulation for 72 hours: 92 ± 17 pg/ml,
P = 0.005, n = 3 mice, experiments performed in triplicates;
Figure 2B).
During repetitive antigen-stimulation, CD8+ T cells
with strong IL-2 receptor α (CD25) expression
represent a population of rather short-lived effector
cells, whereas those with low CD25 expression form a
population of rather long-lived memory cells [22]. To
examine an effect of the CD8+ T cell activation status
on the rate of glutamate release, splenocytes from OT-I
mice were repetitively stimulated by incubation for
time intervals of 72 hours with OVA-peptide257-264
(SIINFEKL; 1 nM) and IL-2 (500 IU/ml) for a total of 15
days. Single CD8+ T cell glutamate secretion rates were
determined from the supernatant glutamate concentra-
tions and cell numbers at the end of each stimulation
interval (see Methods; Figure 2D). In parallel, flow cy-
tometry was repetitively performed for activation
markers CD69 and CD25 (Figure 2C). CD69 expres-
sion levels peaked after 12 hours of stimulation and
went back to baseline levels afterwards (CD69: mean
fluorescence intensity (MFI): day 0: 5.6 ± 4.2, day 0.5:
20.6 ± 3.2, P = 0.015). In contrast, both CD25 expres-
sion levels and single CD8+ T cell glutamate secretion
rates increased during the two stimulation intervals,
peaked at day 6, and subsequently decreased back to-
wards baseline levels (CD25: mean fluorescence inten-
sity (MFI): day 0: 2.5 ± 1.2, day 6: 43.3 ± 12.5, P =
0.002; glutamate secretion rate: day 3: 3.8 ± 1.8 fmol/h/
cell, day 6: 41.1 ± 16.0 fmol/h/cell, P = 0.034;
Figure 2C,D) suggesting glutamate liberation as a pos-
sible effector mechanism of antigen-activated CD8+ T
cells.
Figure 2 Upon antigen-dependent stimulation CD8+ T effector cells exhibit higher estimated single cell glutamate release rates than
CD8+ T memory cells. (A, B) Supernatant glutamate (A) and IFNγ (B) concentrations determined after 72 hours of stimulation of splenocytes
from OT-I mice bearing a transgenic ovalbumin (OVA)-reactive TCR with or without OVA-peptide257-264 (SIINFEKL; 1 nM) and IL-2 (500 IU/ml)
(n = 3 mice, experiments performed in triplicates). (C, D) Time course of T cell activation marker expression (mean fluorescence intensity (MFI) for
CD69 and CD25; (C) and estimated single cell glutamate secretion rates (ΔGlu/Δt/cell; (D) during repetitive stimulation of splenocytes from OT-I
mice by incubation for time intervals of 72 hours with OVA-peptide257-264 (SIINFEKL; 1 nM) and IL-2 (500 IU/ml) (n = 3 mice, experiments
performed in triplicates).
Melzer et al. Journal of Neuroinflammation 2013, 10:121 Page 7 of 13
http://www.jneuroinflammation.com/content/10/1/121Antigen-dependent glutamate release from CD8+ T cells
causes excitotoxic neuronal cell death during an
oligodendrocyte-directed CD8+ T cell attack in the CNS
gray matter
Glutamate release from activated CD8+ T cell might repre-
sent an effector mechanism in autoimmune CNS inflam-
mation due to the ubiquitous expression of synaptic and
extrasynaptic ionotropic glutamate receptors in neurons
[23], which renders them highly sensitive to excitotoxic
cell death. Moreover, encephalitogenic CD8+ T cells are
known to migrate through the CNS parenchyma making
short-lasting direct contacts with parenchymal cells in
search of their cognate antigen. Upon antigen-recognition,
CD8+ T cells make long-lasting contacts with their target
cells and exert direct and collateral [4,7,12] cytotoxic
effects. In the intact CNS parenchyma, glutamate is
efficiently cleared from the extracellular space through
(re-)uptake by high-affinity glial and neuronal excitatory
amino acid transporters (EAATs; [24]). Thus, relevant
excitotoxic effects of CD8+ T cell-mediated glutamate lib-
eration can only be studied in the intact CNS parenchyma.
As a first step, we tested the glutamate sensitivity of cul-
tured neurons from WT C57BL/6 mice by two independent
approaches: (i) cultured neurons were incubated for 30minutes with standard artificial cerebrospinal fluid (ACSF)
supplemented with different concentrations of L-glutamate
(0, 100 and 1,000 μM) followed by a washout for 30 minutes
with standard ACSF (Figure 3A-C). Glutamate exposition
dose-dependently and reversibly increased the proportion of
MAP2+ neurons showing focal swellings of their neurites,
that is neuronal beading [13] (fraction of beading cells: con-
trol with 0 μM glutamate: 4.5 ± 2.0%; 100 μM glutamate:
20.7 ± 5.8%, P = 0.04, washout: 4.5 ± 1.4%, P = 0.04; 1,000
μM glutamate: 50.3 ± 6.3, P = 0.003, washout: 4.6 ± 0.6%,
P = 0.02; n = 5 respectively); (ii) cultured neurons were incu-
bated for six hours with standard ACSF supplemented with
or without L-glutamate (100 μM; Figure 4A-D). The pro-
portion of NeuN+ neurons staining positive for activated
caspase-3 was calculated before and after six hours of incu-
bation as a percentage of all NeuN+ cells. After six hours
of exposition to glutamate-containing ACSF, the fraction of
activated caspase-3+ NeuN+ neurons was significantly in-
creased compared to incubation with ACSF without glu-
tamate (incubation for 0 hours: 13.2 ± 3.4%; incubation
for six hours: ACSF without glutamate: 18.6 ± 3.8%, ACSF
with 100 μM glutamate: 67.3 ± 9.6%, P = 0.009). Hence,
caspase-3 activation occurs as a consequence of exposure
of neurons to toxic amounts of glutamate [25-28].
Figure 3 Neurons exposed to glutamate reversibly and dose-dependently exhibit focal swellings of their neurites, that is neuronal
beading. (A-D) L-glutamate exposition (0, 100 and 1,000 μM) for 30 minutes followed by washout for 30 minutes dose-dependently and
reversibly increased the proportion of cultured neurons showing focal swellings of their neurites, that is neuronal beading. (A-C) Representative
images showing cultured neurons (MAP2, green; DAPI, blue) before (A) and after (B) 30 minutes of exposition to 100 μM glutamate as well as
after another 30 minutes of wash-out (C). (D) Fraction of beading neurons under distinct experimental conditions (n = 5 respectively).
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excessive stimulation of ionotropic glutamate receptors
and can be effectively inhibited by MK801 (blocking
NMDA-receptors at a concentration of 10 μM; [29] and
NBQX (blocking AMPA-/kainate-receptors at a concen-
tration of 30 μM; [29]).
First, we tested the impact of MK801 and NBQX at
the respective concentrations on the killing behavior of
activated OT-I T cells using glutamate-insensitive murine
EL-4 lymphoma cells [30] loaded with OVA-peptide257-264
(SIINFEKL; 1 nM) as target cells (effector-to-target cell ra-
tio 1:1; [10]; Figure 5). The amount of ATP in the super-
natant following cell lysis was assessed as a parameter of
target cell viability. As a control, supernatant ATP levels
were determined from 0, 50 000 and 100 000 EL-4 cells
and activated OT-I T cells cultured separately for six hours
(n = 3 mice, experiments performed in triplicates). Under
all conditions, supernatant ATP levels showed a linear
dependence on the number of cultured cells (Figure 5A).
In the absence of OVA-peptide257-264 loading of EL-4 cells,
supernatant ATP levels upon co-culture with activated OT-I
T cells were approximately the sum of those obtained by
separate culture of both cell types (EL-4 cells: 200 949 ± 12
298 cpm, OT-I T cells: 154 765 ± 6 131 cpm, EL-4 cells +OT-I T cells - OVA-peptide: 436 011 ± 8 309 cpm) making
relevant antigen-independent cytotoxicity unlikely. In con-
trast, OVA-peptide257-264 loading of EL-4 cells significantly
reduced supernatant ATP levels upon co-culture with acti-
vated OT-I T cells (EL-4 cells + OT-I T cells + OVA-
peptide: 204 716 ± 10 553 cpm, P < 0.001) consistent with a
strong killing efficacy. MK801 and NBQX at the respective
concentrations had no impact on the OT-I T cell killing effi-
cacy (EL-4 cells + OT-I T cells + OVA-peptide + MK801/
NBQX: 214 982 ± 6 812 cpm, P = 0.148, n = 3 mice, experi-
ments performed in triplicates for all experimental groups;
Figure 5B).
To exclude relevant self-killing of OT-I T cells due to
OVA-peptide257-264 loading of their MHC I molecules, we
used EG-7 cells as targets, which constitutively present
OVA-peptide257-264 in the context of MHC I [10] and
obtained the same results (EG-7 cells + OT-I T cells: 259
042 ± 24 119 cpm; EG-7 cells + OT-I T cells + MK801/
NBQX: 199 698 ± 25 930 cpm, P = 0.143, n = 3 mice, exper-
iments performed in triplicates for all experimental groups,
data not shown). Hence, glutamate receptor blockers did
not impact the killing efficacy as a measure of migration, tar-
get cell recognition and exertion of effector functions of acti-
vated CD8+ T cells. They can thus be used to study the
Figure 4 Caspase-3 activation in neurons exposed to glutamate. (A, B) Representative double staining for activated caspase-3 (red) in
cultured neurons (NeuN, green; DAPI, blue) before (A) and after exposure to 0 μM (B) or 100 μM (C) L-glutamate for six hours. (D) Fraction of
activated caspase-3+ neurons under distinct experimental conditions (n = 5 respectively).
Figure 5 Ionotropic glutamate receptor blockers NBQX and MK801 do not impact antigen-dependent CD8+ T cell mediated killing of
murine lymphoma cells. (A, B) Impact of ionotropic glutamate receptor blockers MK801 (10 μM) and NBQX (30 μM) on the killing behavior
of activated OT-I T cells using murine EL-4 lymphoma cells loaded with ovalbumin (OVA)- peptide257-264 (SIINFEKL; 1 nM) as target cells
(effector-to-target cell ratio 1:1). The amount of ATP in the supernatant following cell lysis was assessed as a parameter of target cell viability.
(A) Supernatant ATP levels determined from 0, 50,000 and 100,000 EL-4 cells and activated OT-I T cells cultured separately for six hours
demonstrate a linear dependence on the number of cultured cells (n = 3 mice, experiments performed in triplicates). (B) In the absence of
OVA-peptide257-264 loading of EL-4 cells (EL4), supernatant ATP levels upon co-culture with activated OT-I T cells (OT-I) were approximately
the sum of those obtained by separate culture of both cell types (EL-4 + OT-I-OVA). OVA-peptide257-264 loading of EL-4 cells significantly
reduced supernatant ATP levels upon co-culture with activated OT-I T cells (EL-4 + OT-I + OVA) for six hours. MK801 and NBQX had no impact
on the killing efficacy (EL-4 + OT-I + OVA + MK801/NBQX; n = 3 mice, experiments performed in triplicates for all experimental groups).
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excitotoxic neuronal cell death within the intact CNS
parenchyma.
To this end, we transferred activated OT-I T cells [5]
into acute brain slices from mice selectively expressing
OVA in oligodendrocytes (ODC-OVA mice [6]) and
tracked collateral neuronal cell death in the cortical gray
matter via double-staining for NeuN and activated caspase-
3 [7,10]. After six hours exposure to activated OT-I T cells,
the fraction of activated caspase-3+ neurons was signifi-
cantly increased compared to control conditions without
OT-I T cell incubation (OT-I T cells: 32.1 ± 4.0%; control:
5.2 ± 0.8%, P = 0.008). Moreover, glutamate receptor block-
ade with NBQX and MK801 significantly reduced neuronalFigure 6 Antigen-dependent glutamate release from CD8+ T cells cau
oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter. (
brain slices from ODC-OVA mice in the absence (A, OT-I) or presence (B, O
neuronal cell death (white arrows) in the cortical gray matter was tracked v
As controls, acute brain slices from ODC-OVA mice were left untreated (C,
MK801 and NBQX (E, NBQX MK801, 10 μM and 30 μM) for six hours. (F) Fra
gray matter of acute brain slices from ODC-OVA mice under the distinct ex
for all experimental groups).cell death (OT-I T cells: 32.1 ± 4.0%; OT-I T cells +
MK801/NBQX: 13.6 ± 1.9%, P < 0.001). Importantly, incu-
bation with NBQX and MK801 did not reduce background
levels of neuronal cell death in the absence of incubation
with OT-I T cells (MK801/NBQX: 6.4 ± 0.9%, P = 0.236)
ruling out unspecific inhibition of excitotoxicity in the ab-
sence of T cells. Furthermore, incubation for six hours with
L-glutamate at a concentration of 100 μM significantly in-
creased the fraction of activated caspase-3+ neurons com-
pared to control conditions (glutamate: 11.2 ± 1.8%, P =
0.041, n = 3 mice, each providing three brain slices for all
experimental groups; Figure 6) corroborating caspase-3 ac-
tivation in neurons undergoing excitotoxic cell death within
the intact CNS parenchyma.ses collateral excitotoxic neuronal cell death during an
A-F) Activated OT-I T cells were incubated for six hours [5] in acute
T-I NBQX MK801) of MK801 (10 μM) and NBQX (30 μM), and collateral
ia staining for NeuN (green), DAPI (blue) and activated caspase-3 (red).
control), or incubated either with L-glutamate (D, Glu, 300 μM) or with
ctions of activated caspase-3+ NeuN+ neurons detected in the cortical
perimental conditions (n = 3 mice, each providing three brain slices
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CD8+ T cell-mediated neuronal cell death is a relevant
pathogenic mechanism in a variety of inflammatory
CNS disorders [4]. CD8+ T cell cytotoxicity within the
CNS is predominantly mediated via two independent
pathways depending on the strength of the antigen-signal
(that is, the number of antigen-peptide loaded major
histocompatibility complex class I (pMHC I) molecules
and the affinity of the CD8+ T cell receptor (TCR) complex
to the pMHC I complex) delivered by the glial or neuronal
target cell [31,32]. Strong antigen-signals promote killing
via CD8+ T cell-mediated perforin and granzyme exocyt-
osis and perforin-dependent delivery of granzymes into
the target cell, whereas weak antigen-signals favor killing
via interaction of CD8+ T cell-derived Fas-ligand (FasL)
with the Fas-receptor (Fas) on the target cell surface
[31-33]. Moreover, CD8+ T cells are able to contribute to
inflammatory tissue damage by release of proinflammatory
cytokines such as IFNγ and tumor necrosis factor-(TNF)α
[34]. These CD8+ T cell effector mechanisms impair
electrical signaling [12] and cause cell death of neurons
as direct and ‘collateral’ target cells [4,7].
Glutamate excitotoxicity is known to contribute to neur-
onal damage in autoimmune CNS inflammation [35-37].
Under inflammatory conditions, glutamate is known to be
released from microglia and astrocytes [13,20].
We provide evidence of glutamate release as another
crucial effector pathway of CD8+ T cells leading to ‘col-
lateral’ excitotoxic neuronal degeneration during an
oligodendrocyte-directed CD8+ T cell attack in the CNS
gray matter. Following TCR stimulation, CD8+ T cells ac-
quire the molecular repertoire for vesicular glutamate release:
(i) they upregulate expression of glutaminase required to
generate glutamate via deamination of glutamine and (ii)
they upregulate expression of vesicular proton-ATPase and
vesicular glutamate transporters required for filling of vesicles
with glutamate. In contrast, there was no evidence for non-
vesicular mechanisms of glutamate liberation. Furthermore,
CD25high CD8+ T effector cells exhibit higher estimated sin-
gle cell glutamate release rates than CD25low CD8+ T mem-
ory cells underpinning glutamate liberation as a possible
effector mechanism of antigen-activated CD8+ T cells enter-
ing the CNS. Moreover, activated oligodendrocyte-reactive
CD25high CD8+ T effector cells cause ‘collateral’ neuronal
cell death within intact cortical gray matter of acute brain
slices which can partially be blocked by a combination of
ionotropic glutamate receptor antagonists. Hence, glutamate
liberation by oligodendrocyte-reactive CD8+ T cells is cap-
able of eliciting excitotoxic cell death of neurons despite glu-
tamate reuptake by glia and neurons in the intact CNS gray
matter [24]. Encephalitogenic CD8+ T cells (in contrast to
CD4+ T cells) make close contacts with their target cells in
the CNS [12] and release proinflammatory cytokines
which may reinforce local glutamate excitotoxicity: TNFαis known to reduce the expression of EAATs and detoxify-
ing enzymes in glia cells limiting their glutamate uptake
capacity [38,39]. IFNγ has been shown to exert neurotox-
icity by gating a calcium-permeable complex of the IFNγ
receptor and AMPA glutamate receptor in neurons [40].
Moreover, neuron-reactive CD8+ T cells which directly
contact neurites induce cytoskeleton breaks with adjacent
neuritic spheroids [41] closely resembling neuronal bead-
ing upon exposition to glutamate [13]. Importantly, it has
been demonstrated that cell death in mature but not imma-
ture cultured neurons treated with cytotoxic secretory gran-
ules isolated from CD8+ T cells can be inhibited by blockers
of ionotropic (NMDA- but not AMPA-) but not metabotro-
pic glutamate receptors [30]. As in our case, this effect was
neuron-specific as glutamate receptor blocker failed to pro-
tect glutamate-insensitive lymphoma cells from secretory
granule-induced cytotoxicity [30]. Moreover, blocking of
neuronal glutamate reuptake did not significantly enhance
killing of neurons elicited by secretory granules, and relevant
glutamate concentrations could not be detected in the cul-
ture supernatant. This refutes the possibility that significant
neuronal (auto-)toxicity was induced by vesicular or non-
vesicular release of glutamate from neurons following their
perforin-mediated depolarization [12] upon treatment with
secretory granules [30]. However, these findings are consist-
ent with storage of glutamate in secretory granules which
together with perforin and granzymes elicits neuronal cal-
cium overload and cell death.
Conclusions
Facing excess numbers of target cells, CNS-invading
CD8+ T cells may kill neurons either via confined release
of cytotoxic effector molecules towards the neuron or
via spillover of cytotoxic effector molecules from ‘leaky’
immunological synapses and non-confined release by
CD8+ T cells themselves during serial and simultaneous
killing of oligodendrocytes or astrocytes. In both scenar-
ios glutamate-mediated excitotoxicity may contribute to
neuronal cell death.
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splenocytes (see Methods) yielding a purity of about 90% of CD8+ cells
(A) of which about 90% were CD3+ T cells (B) as revealed by standard
flow cytometry analysis. (C) The presence of a variety of glutamate
release blockers (see text) did not affect the activation status of CD8+
T cells after 72 hours (d 3) of CD3/28 bead-stimulation as under all
conditions the fraction of activated CD8+ CD25+ T cells was > 95%,
whereas it was < 1% before CD3/28 bead-stimulation (d 0). (D) The
presence of a variety of glutamate release blockers (see text) did not
impact CD8+ T cell viability after 72 hours (d 3) of CD3/28 bead-stimulation
as the fraction of viable annexin V- PI- cells was always > 90%.
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